HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma (vol 20, 537, 2022)

被引：1
|
作者：
Jia, Chuiming [1 ]
Guo, Yiwei [1 ]
Chen, Yao [1 ]
Wang, Xinya [1 ]
Xu, Qiuting [1 ]
Zhang, Yu [2 ]
Quan, Lina [1 ]
机构：
[1] Harbin Med Univ, Canc Hosp, Hematol Dept, Harbin, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Immunol Dept, Harbin, Heilongjiang, Peoples R China
来源：
JOURNAL OF TRANSLATIONAL MEDICINE | 2023年 / 21卷 / 01期
关键词：
D O I：
10.1186/s12967-023-03904-2
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma
    Chuiming Jia
    Yiwei Guo
    Yao Chen
    Xinya Wang
    Qiuting Xu
    Yu Zhang
    Lina Quan
    Journal of Translational Medicine, 20
  • [2] HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma
    Quan, Lina
    Jia, Chuiming
    Guo, Yiwei
    Chen, Yao
    Wang, Xinya
    Xu, Qiuting
    Zhang, Yu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [3] Correction: HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma
    Chuiming Jia
    Yiwei Guo
    Yao Chen
    Xinya Wang
    Qiuting Xu
    Yu Zhang
    Lina Quan
    Journal of Translational Medicine, 21
  • [4] HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2
    Jiang, Juan
    Zhu, Jiamei
    Qiu, Ping
    Ni, Jie
    Zhu, Wei
    Wang, Xinyan
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2024, 24 (01)
  • [5] HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2
    Juan Jiang
    Jiamei Zhu
    Ping Qiu
    Jie Ni
    Wei Zhu
    Xinyan Wang
    Functional & Integrative Genomics, 2024, 24
  • [6] lncRNA ST3GAL6-AS1 promotes invasion by inhibiting hnRNPA2B1-mediated ST3GAL6 expression in multiple myeloma
    Shen, Ying
    Feng, Yuandong
    Li, Fangmei
    Jia, Yachun
    Peng, Yue
    Zhao, Wanhong
    Hu, Jinsong
    He, Aili
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2021, 58 (04)
  • [7] m6A reader hnRNPA2B1 drives multiple myeloma osteolytic bone disease
    Liu, Rui
    Zhong, Yuping
    Chen, Rui
    Chu, Chengchao
    Liu, Gang
    Zhou, Yong
    Huang, Yazhu
    Fang, Zhihong
    Liu, Huan
    THERANOSTICS, 2022, 12 (18): : 7760 - 7774
  • [8] FTO-mediated m6A modification of SOCS1 mRNA promotes the progression of diabetic kidney disease
    Sun, Qiangr
    Geng, Houfa
    Zhao, Meng
    Li, Yang
    Chen, Xi
    Sha, Qian
    Lai, Peng
    Tang, Daoquan
    Yang, Dongzhi
    Liang, Jun
    Guo, Mengzhe
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (06):
  • [9] hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner
    Hao, Weijie
    Chen, Zhimin
    Tang, Jingzhi
    Yang, Ru
    Gao, Wei-Qiang
    Xu, Huiming
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [10] hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner
    Weijie Hao
    Zhimin Chen
    Jingzhi Tang
    Ru Yang
    Wei-Qiang Gao
    Huiming Xu
    Journal of Translational Medicine, 21
12345